Clinical Focus
Adult Immunization
Allergy & Immunology
Cardiology
Dermatology
Endocrinology
Gastroenterology
Infectious Disease
Men’s Health
Nephrology
Neurology
Pain Management
Pediatric Immunization
Pediatrics
Psychiatry
Pulmonology
Rheumatology
Women’s Health
Business Focus
Billing and Collections
Career Planning
Coding and Documentation
Concierge Medicine
Cybersecurity
EHRs
Investing
Patient Relations
Personal Finance
Practice Management
Remote Patient Monitoring
Staffing
Technology
Telehealth
Value-based Care
Spotlight
Unmet Needs in Managing MDD
Interpreting Thyroid Function Tests
Using Thyroid Lab Tests
Testing & Screening to Optimize Men's Health
All News
Office Procedures
Practice Management
Around the Practice
Between the Lines
ConsultantLive
Expert Interviews
Medical World News
Podcasts
Primary View
Provider Toolkits
Readout360
Conference Coverage
Conference Listing
Image IQ
Interactive Posters
Podcasts
Polls
Quizzes
Sponsored Resources
eNewsletter
CE/CME
Advertisement
Contact Info
2 Clarke Drive
Cranbury, NJ 08512
© 2023 MJH Life Sciences
All rights reserved.
All rights reserved.
Social Determinants of Health and Prevention of Cardiovascular Disease
Research demonstrates that socioeconomic inequalities are "strong determinants" of cardiovascular risk throughout the world.
Members of the writing committee for the American College of Cardiology/American Heart Association 2019 Guideline on Primary Prevention of Cardiovascular Disease incorporated throughout the guideline consideration of how social determinants of health may impact the efficacy of specific guidance and prescriptions for an individual patient. ACC/AHA recommends that clinicians revisit these considerations at each follow-up visit.
Considerations include but are not limited to socioeconomic and educational status as well as cultural, home, and employment environments. The slides below highlight examples of considerations cited by the ACC/AHA for 7 health domains.
Daily Dose: Waist-to-Hip Ratio Better Predictor for Mortality than BMI?
Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care
One or More Cardiac, Renal, or Metabolic Conditions Affect 25% of US Adults
Obesity & Type 2 Diabetes: An Expert Discussion
Investigational Nasal Spray Found Safe, Effective for Self-Treatment of Paroxysmal Supraventricular Tachycardia
GLP-1 Mimetics, SGLT-2 Inhibitors Understudied in Black Populations in Pivotal Trials, Benefits Questioned
Daily Dose: Waist-to-Hip Ratio Better Predictor for Mortality than BMI?
Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care
One or More Cardiac, Renal, or Metabolic Conditions Affect 25% of US Adults
Obesity & Type 2 Diabetes: An Expert Discussion
Investigational Nasal Spray Found Safe, Effective for Self-Treatment of Paroxysmal Supraventricular Tachycardia
GLP-1 Mimetics, SGLT-2 Inhibitors Understudied in Black Populations in Pivotal Trials, Benefits Questioned
Daily Dose: Waist-to-Hip Ratio Better Predictor for Mortality than BMI?
Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care
One or More Cardiac, Renal, or Metabolic Conditions Affect 25% of US Adults
Obesity & Type 2 Diabetes: An Expert Discussion
Investigational Nasal Spray Found Safe, Effective for Self-Treatment of Paroxysmal Supraventricular Tachycardia
GLP-1 Mimetics, SGLT-2 Inhibitors Understudied in Black Populations in Pivotal Trials, Benefits Questioned
Daily Dose: Waist-to-Hip Ratio Better Predictor for Mortality than BMI?
September 29th 2023Your daily dose of the clinical news you may have missed.
Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care
August 30th 2023Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.
One or More Cardiac, Renal, or Metabolic Conditions Affect 25% of US Adults
September 29th 2023The prevalence of cardiac, renal, and metabolic conditions has significantly increased over 20 years and so has the number of US adults who have all 3.
Obesity & Type 2 Diabetes: An Expert Discussion
June 30th 2023In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.
Investigational Nasal Spray Found Safe, Effective for Self-Treatment of Paroxysmal Supraventricular Tachycardia
September 27th 2023Etripamil 70 mg nasal spray restored heart rate within 30 minutes in approximately 60% of PSVT episodes, report authors of new study.
GLP-1 Mimetics, SGLT-2 Inhibitors Understudied in Black Populations in Pivotal Trials, Benefits Questioned
September 26th 2023Pivotal cardiovascular outcome trials that evaluated cardiorenal benefits of the newer classes were not designed to consider racial/ethnic variations, researchers state.